This paper reports on the identification and full chemical characterization of the substance colloquially called “etonitazepyne” or “ N ‐pyrrolidino etonitazene” (2‐(4‐ethoxybenzyl)‐5‐nitro‐1‐(2‐(pyrrolidin‐1‐yl)ethyl)‐1 H ‐benzo[ d ]imidazole), a potent NPS opioid of the 5‐nitrobenzimidazole class. Identification of etonitazepyne was performed, on a sample purchased during routine monitoring of the drug market, using GC‐MS, HRAM LC‐MS/MS, 1 H NMR, and FTIR. The chromatographic data, together with the FTIR data, indicated the presence of a highly pure compound and already indicated a benzimidazole structure. The specific benzimidazole regio‐isomer was confirmed using 1 H NMR spectroscopy, resulting in the unambiguous identification of etonitazepyne.
No takes yet. Share an insight, caveat, or question.
Blanckaert et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: